These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8808693)

  • 1. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R; Dudek H; Patel G; Reddy EP
    Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
    Dudek H; Reddy EP
    Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
    Dasgupta P; Reddy EP
    Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and mechanism of activation of the myb oncogene.
    Rosson D; Reddy EP
    Gene Amplif Anal; 1986; 4():99-108. PubMed ID: 3333363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of alternate and truncated forms of murine c-myb proteins.
    Ramsay RG; Ishii S; Nishina Y; Soe G; Gonda TJ
    Oncogene Res; 1989; 4(4):259-69. PubMed ID: 2549488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of the chicken c-myb exon 9A.
    Schuur ER; Dasgupta P; Reddy EP; Rabinovich JM; Baluda MA
    Oncogene; 1993 Jul; 8(7):1839-47. PubMed ID: 8510928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
    Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
    Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
    Thompson MA; Flegg R; Westin EH; Ramsay RG
    Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of c-myb exon 9 induced by insertion of repeats.
    Shinagawa T; Ishiguro N; Horiuchi M; Matsui T; Okada K; Shinagawa M
    Oncogene; 1997 Jun; 14(23):2775-83. PubMed ID: 9190893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential splicing of the mouse B-myb gene.
    Kamano H; Burk B; Noben-Trauth K; Klempnauer KH
    Oncogene; 1995 Dec; 11(12):2575-82. PubMed ID: 8545114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two translational products for c-myb.
    Dudek H; Reddy EP
    Oncogene; 1989 Sep; 4(9):1061-6. PubMed ID: 2674850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia.
    Bies J; Koller R; Hoffman B; Amanullah A; Mock B; Wolff L
    Leukemia; 1997 Apr; 11 Suppl 3():247-50. PubMed ID: 9209355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
    Bies J; Wolff L
    Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a second promoter in the human c-myb proto-oncogene.
    Jacobs SM; Gorse KM; Westin EH
    Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
    Bies J; Mukhopadhyaya R; Pierce J; Wolff L
    Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of the human c-myb gene.
    Westin EH; Gorse KM; Clarke MF
    Oncogene; 1990 Aug; 5(8):1117-24. PubMed ID: 2202948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.